MeSH tree: G07.690.773.984.269
Tuberculosis (TB) is the world's biggest infectious disease killer, with multidrug-resistant TB (MDR-TB) posing a particular threat to global health. A study led by the Swiss Tropical and Public Health Institute (Swiss TPH) ...
Jan 6, 2025
0
62
Antibiotic shortages disrupt patient care, increase treatment costs, reduce effectiveness, and contribute to the rise of antibiotic resistance globally.
Dec 16, 2024
0
24
The ADAPT-Sepsis research group has demonstrated that using procalcitonin (PCT) as a biomarker to guide antibiotic duration in critically ill adults with suspected sepsis can significantly reduce treatment length without ...
A recent study published in Clinical Infectious Diseases has uncovered an increase in severe multidrug-resistant (MDR) Shigella sonnei infections, particularly among people experiencing homelessness (PEH) in Vancouver, Canada. ...
Dec 5, 2024
0
13
It has been a year ago since bacteria from war-wounded at hospitals in Ukraine were analyzed. The study, which attracted a lot of attention, showed that some of the bacteria types had total resistance to antibiotics. Now, ...
Nov 25, 2024
0
35
An international clinical trial of more than 3,600 patients in 74 hospitals, and involving Monash University researchers, has shown that a traditional long course of antibiotics for bloodstream infection is not necessary.
Nov 21, 2024
0
17
The discovery of antibiotics is one of the greatest medical breakthroughs of the 20th century. Before antibiotics, childbirth, a urinary tract infection, or a simple cut could lead to death from infection.
Nov 21, 2024
0
16
Antimicrobial resistance happens when bacteria and other microbes that can cause infections gain the ability to resist treatment by antibiotics or other antimicrobial medicines.
Nov 21, 2024
0
16
Doctors may soon use an AI-driven solution to swiftly prescribe a personalized antibiotic regimen for patients with just a few mouse clicks instead of giving general treatment. The antibiotic regimen can then be adjusted, ...
Nov 19, 2024
0
17
In his recent doctoral thesis, defended at the University of Helsinki, Matej Zore investigated two drugs, fingolimod and etrasimod—initially developed to treat autoimmune diseases—for their potential to fight drug-resistant ...
Nov 18, 2024
0
17
